APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sepsis and Septic Shock Treatment

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Sepsis and Septic Shock Treatment Industry Growth and Trends Forecast to 2032

2 January 2026111 pages

Choose your research edition.

Industry ResearchSepsis and Septic Shock Treatment Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Sepsis and Septic Shock Treatment Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Sepsis and Septic Shock Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sepsis and Septic Shock Treatment Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Sepsis and Septic Shock Treatment Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

According to APO Research, the global Sepsis and Septic Shock Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Sepsis and Septic Shock Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Sepsis and Septic Shock Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sepsis and Septic Shock Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Sepsis and Septic Shock Treatment market include TEVA, Johnson & Johnson, Novartis, Pfizer, GlaxoSmithKline, Bayer, AbbVie, Viatris and Shanghai Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Sepsis and Septic Shock Treatment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Sepsis and Septic Shock Treatment market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Sepsis and Septic Shock Treatment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Sepsis and Septic Shock Treatment.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Sepsis and Septic Shock Treatment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Sepsis and Septic Shock Treatment Market by Company

TEVA

Johnson & Johnson

Novartis

Pfizer

GlaxoSmithKline

Bayer

AbbVie

Viatris

Shanghai Pharmaceuticals

NCPC

Merck & Co

INOTREM

Endacea

AtoxBio

Asahi Kasei

Adrenomed

Sepsis and Septic Shock Treatment Segment by Type

Macrolides

Pencillin

Cephalosporin

Others

Sepsis and Septic Shock Treatment Segment by Application

Sepsis

Septic Shock

Sepsis and Septic Shock Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sepsis and Septic Shock Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sepsis and Septic Shock Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sepsis and Septic Shock Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Sepsis and Septic Shock Treatment companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Sepsis and Septic Shock Treatment Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Sepsis and Septic Shock Treatment Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Sepsis and Septic Shock Treatment Market Share by Region (2021-2026) Table 4. Global Sepsis and Septic Shock Treatment Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Sepsis and Septic Shock Treatment Market Share by Region (2027-2032) Table 6. Global Sepsis and Septic Shock Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Sepsis and Septic Shock Treatment Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Sepsis and Septic Shock Treatment Market Size Share by Type (2021-2026) Table 9. Global Sepsis and Septic Shock Treatment Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Sepsis and Septic Shock Treatment Market Size Share Forecasted by Type (2027-2032) Table 11. North America Sepsis and Septic Shock Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Sepsis and Septic Shock Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Sepsis and Septic Shock Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Sepsis and Septic Shock Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Sepsis and Septic Shock Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Sepsis and Septic Shock Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Sepsis and Septic Shock Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Sepsis and Septic Shock Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Sepsis and Septic Shock Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Sepsis and Septic Shock Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Sepsis and Septic Shock Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Sepsis and Septic Shock Treatment Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Sepsis and Septic Shock Treatment Market Size Share by Application (2021-2026) Table 24. Global Sepsis and Septic Shock Treatment Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Sepsis and Septic Shock Treatment Market Size Share Forecasted by Application (2027-2032) Table 26. North America Sepsis and Septic Shock Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Sepsis and Septic Shock Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Sepsis and Septic Shock Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Sepsis and Septic Shock Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Sepsis and Septic Shock Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Sepsis and Septic Shock Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Sepsis and Septic Shock Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Sepsis and Septic Shock Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Sepsis and Septic Shock Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Sepsis and Septic Shock Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Sepsis and Septic Shock Treatment Industry Trends Table 37. Sepsis and Septic Shock Treatment Industry Drivers Table 38. Sepsis and Septic Shock Treatment Industry Opportunities and Challenges Table 39. Sepsis and Septic Shock Treatment Industry Restraints Table 40. Global Sepsis and Septic Shock Treatment Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Sepsis and Septic Shock Treatment Revenue Market Share by Company (2021-2026) Table 42. Global Sepsis and Septic Shock Treatment Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Sepsis and Septic Shock Treatment Key Company Headquarters & Area Served Table 44. Global Sepsis and Septic Shock Treatment Company, Product Type & Application Table 45. Global Sepsis and Septic Shock Treatment Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Sepsis and Septic Shock Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. TEVA Company Information Table 49. TEVA Business Overview Table 50. TEVA Sepsis and Septic Shock Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. TEVA Sepsis and Septic Shock Treatment Product Portfolio Table 52. TEVA Recent Development Table 53. Johnson & Johnson Company Information Table 54. Johnson & Johnson Business Overview Table 55. Johnson & Johnson Sepsis and Septic Shock Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Johnson & Johnson Sepsis and Septic Shock Treatment Product Portfolio Table 57. Johnson & Johnson Recent Development Table 58. Novartis Company Information Table 59. Novartis Business Overview Table 60. Novartis Sepsis and Septic Shock Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Novartis Sepsis and Septic Shock Treatment Product Portfolio Table 62. Novartis Recent Development Table 63. Pfizer Company Information Table 64. Pfizer Business Overview Table 65. Pfizer Sepsis and Septic Shock Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Pfizer Sepsis and Septic Shock Treatment Product Portfolio Table 67. Pfizer Recent Development Table 68. GlaxoSmithKline Company Information Table 69. GlaxoSmithKline Business Overview Table 70. GlaxoSmithKline Sepsis and Septic Shock Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. GlaxoSmithKline Sepsis and Septic Shock Treatment Product Portfolio Table 72. GlaxoSmithKline Recent Development Table 73. Bayer Company Information Table 74. Bayer Business Overview Table 75. Bayer Sepsis and Septic Shock Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Bayer Sepsis and Septic Shock Treatment Product Portfolio Table 77. Bayer Recent Development Table 78. AbbVie Company Information Table 79. AbbVie Business Overview Table 80. AbbVie Sepsis and Septic Shock Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. AbbVie Sepsis and Septic Shock Treatment Product Portfolio Table 82. AbbVie Recent Development Table 83. Viatris Company Information Table 84. Viatris Business Overview Table 85. Viatris Sepsis and Septic Shock Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Viatris Sepsis and Septic Shock Treatment Product Portfolio Table 87. Viatris Recent Development Table 88. Shanghai Pharmaceuticals Company Information Table 89. Shanghai Pharmaceuticals Business Overview Table 90. Shanghai Pharmaceuticals Sepsis and Septic Shock Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Shanghai Pharmaceuticals Sepsis and Septic Shock Treatment Product Portfolio Table 92. Shanghai Pharmaceuticals Recent Development Table 93. NCPC Company Information Table 94. NCPC Business Overview Table 95. NCPC Sepsis and Septic Shock Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. NCPC Sepsis and Septic Shock Treatment Product Portfolio Table 97. NCPC Recent Development Table 98. Merck & Co Company Information Table 99. Merck & Co Business Overview Table 100. Merck & Co Sepsis and Septic Shock Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Merck & Co Sepsis and Septic Shock Treatment Product Portfolio Table 102. Merck & Co Recent Development Table 103. INOTREM Company Information Table 104. INOTREM Business Overview Table 105. INOTREM Sepsis and Septic Shock Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. INOTREM Sepsis and Septic Shock Treatment Product Portfolio Table 107. INOTREM Recent Development Table 108. Endacea Company Information Table 109. Endacea Business Overview Table 110. Endacea Sepsis and Septic Shock Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Endacea Sepsis and Septic Shock Treatment Product Portfolio Table 112. Endacea Recent Development Table 113. AtoxBio Company Information Table 114. AtoxBio Business Overview Table 115. AtoxBio Sepsis and Septic Shock Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. AtoxBio Sepsis and Septic Shock Treatment Product Portfolio Table 117. AtoxBio Recent Development Table 118. Asahi Kasei Company Information Table 119. Asahi Kasei Business Overview Table 120. Asahi Kasei Sepsis and Septic Shock Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Asahi Kasei Sepsis and Septic Shock Treatment Product Portfolio Table 122. Asahi Kasei Recent Development Table 123. Adrenomed Company Information Table 124. Adrenomed Business Overview Table 125. Adrenomed Sepsis and Septic Shock Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Adrenomed Sepsis and Septic Shock Treatment Product Portfolio Table 127. Adrenomed Recent Development Table 128. North America Sepsis and Septic Shock Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. North America Sepsis and Septic Shock Treatment Market Size by Country (2021-2026) & (US$ Million) Table 130. North America Sepsis and Septic Shock Treatment Market Share by Country (2021-2026) Table 131. North America Sepsis and Septic Shock Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. North America Sepsis and Septic Shock Treatment Market Share Forecast by Country (2027-2032) Table 133. Europe Sepsis and Septic Shock Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe Sepsis and Septic Shock Treatment Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe Sepsis and Septic Shock Treatment Market Share by Country (2021-2026) Table 136. Europe Sepsis and Septic Shock Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe Sepsis and Septic Shock Treatment Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Sepsis and Septic Shock Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Sepsis and Septic Shock Treatment Market Size by Country (2021-2026) & (US$ Million) Table 140. Asia-Pacific Sepsis and Septic Shock Treatment Market Share by Country (2021-2026) Table 141. Asia-Pacific Sepsis and Septic Shock Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Asia-Pacific Sepsis and Septic Shock Treatment Market Share Forecast by Country (2027-2032) Table 143. Latin America Sepsis and Septic Shock Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Latin America Sepsis and Septic Shock Treatment Market Size by Country (2021-2026) & (US$ Million) Table 145. Latin America Sepsis and Septic Shock Treatment Market Share by Country (2021-2026) Table 146. Latin America Sepsis and Septic Shock Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Latin America Sepsis and Septic Shock Treatment Market Share Forecast by Country (2027-2032) Table 148. Middle East & Africa Sepsis and Septic Shock Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Middle East & Africa Sepsis and Septic Shock Treatment Market Size by Country (2021-2026) & (US$ Million) Table 150. Middle East & Africa Sepsis and Septic Shock Treatment Market Share by Country (2021-2026) Table 151. Middle East & Africa Sepsis and Septic Shock Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Middle East & Africa Sepsis and Septic Shock Treatment Market Share Forecast by Country (2027-2032) Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Sepsis and Septic Shock Treatment Product Image Figure 3. Global Sepsis and Septic Shock Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Sepsis and Septic Shock Treatment Market Size (2021-2032) & (US$ Million) Figure 5. Global Sepsis and Septic Shock Treatment Market Share by Region: 2025 VS 2032 Figure 6. Global Sepsis and Septic Shock Treatment Market Share by Region (2021-2032) Figure 7. North America Sepsis and Septic Shock Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Sepsis and Septic Shock Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Sepsis and Septic Shock Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Sepsis and Septic Shock Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Sepsis and Septic Shock Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Macrolides Image Figure 13. Global Macrolides Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Pencillin Image Figure 15. Global Pencillin Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Cephalosporin Image Figure 17. Global Cephalosporin Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Others Image Figure 19. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Sepsis and Septic Shock Treatment Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Sepsis and Septic Shock Treatment Market Share by Type 2025 VS 2032 Figure 22. North America Sepsis and Septic Shock Treatment Market Size Share by Type (2021-2032) Figure 23. Europe Sepsis and Septic Shock Treatment Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Sepsis and Septic Shock Treatment Market Size Share by Type (2021-2032) Figure 25. Latin America Sepsis and Septic Shock Treatment Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Sepsis and Septic Shock Treatment Market Size Share by Type (2021-2032) Figure 27. Sepsis Image Figure 28. Global Sepsis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Septic Shock Image Figure 30. Global Septic Shock Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Sepsis and Septic Shock Treatment Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Sepsis and Septic Shock Treatment Market Share by Application 2025 VS 2032 Figure 33. North America Sepsis and Septic Shock Treatment Market Size Share by Application (2021-2032) Figure 34. Europe Sepsis and Septic Shock Treatment Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Sepsis and Septic Shock Treatment Market Size Share by Application (2021-2032) Figure 36. Latin America Sepsis and Septic Shock Treatment Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Sepsis and Septic Shock Treatment Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Sepsis and Septic Shock Treatment Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Sepsis and Septic Shock Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Sepsis and Septic Shock Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Sepsis and Septic Shock Treatment Market Share by Country (2021-2032) Figure 43. Europe Sepsis and Septic Shock Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Sepsis and Septic Shock Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Sepsis and Septic Shock Treatment Market Share by Country (2021-2032) Figure 46. Asia-Pacific Sepsis and Septic Shock Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Sepsis and Septic Shock Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Sepsis and Septic Shock Treatment Market Share by Country (2021-2032) Figure 49. Latin America Sepsis and Septic Shock Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Sepsis and Septic Shock Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Sepsis and Septic Shock Treatment Market Share by Country (2021-2032) Figure 52. Middle East & Africa Sepsis and Septic Shock Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Sepsis and Septic Shock Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Sepsis and Septic Shock Treatment Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • Macrolides
  • Pencillin
  • Cephalosporin
  • Others
Applications
  • Sepsis
  • Septic Shock
Companies covered
  • TEVA
  • Johnson & Johnson
  • Novartis
  • Pfizer
  • GlaxoSmithKline
  • Bayer
  • AbbVie
  • Viatris
  • Shanghai Pharmaceuticals
  • NCPC
  • Merck & Co
  • INOTREM
  • Endacea
  • AtoxBio
  • Asahi Kasei
  • Adrenomed

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Sepsis and Septic Shock Treatment Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Sepsis and Septic Shock Treatment Market Size by Region (2021-2032)
  5. 1.4.1 Global Sepsis and Septic Shock Treatment Market Size by Region (2021-2026)
  6. 1.4.2 Global Sepsis and Septic Shock Treatment Market Size by Region (2027-2032)
  7. 1.5 Key Regions Sepsis and Septic Shock Treatment Market Size (2021-2032)
  8. 1.5.1 North America Sepsis and Septic Shock Treatment Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Sepsis and Septic Shock Treatment Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Sepsis and Septic Shock Treatment Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Sepsis and Septic Shock Treatment Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Sepsis and Septic Shock Treatment Market Size Growth Rate (2021-2032)
2 Sepsis and Septic Shock Treatment Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Macrolides
  3. 2.1.2 Pencillin
  4. 2.1.3 Cephalosporin
  5. 2.1.4 Others
  6. 2.2 Global Sepsis and Septic Shock Treatment Market Size by Type
  7. 2.2.1 Global Sepsis and Septic Shock Treatment Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Sepsis and Septic Shock Treatment Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Sepsis and Septic Shock Treatment Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Sepsis and Septic Shock Treatment Market Size by Regions
  11. 2.3.1 North America Sepsis and Septic Shock Treatment Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Sepsis and Septic Shock Treatment Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Sepsis and Septic Shock Treatment Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Sepsis and Septic Shock Treatment Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Sepsis and Septic Shock Treatment Market Size Breakdown by Type (2021-2026)
3 Sepsis and Septic Shock Treatment Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Sepsis
  3. 3.1.2 Septic Shock
  4. 3.2 Global Sepsis and Septic Shock Treatment Market Size by Application
  5. 3.2.1 Global Sepsis and Septic Shock Treatment Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global Sepsis and Septic Shock Treatment Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global Sepsis and Septic Shock Treatment Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global Sepsis and Septic Shock Treatment Market Size by Regions
  9. 3.3.1 North America Sepsis and Septic Shock Treatment Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe Sepsis and Septic Shock Treatment Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific Sepsis and Septic Shock Treatment Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America Sepsis and Septic Shock Treatment Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa Sepsis and Septic Shock Treatment Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Sepsis and Septic Shock Treatment Industry Trends
  2. 4.2 Sepsis and Septic Shock Treatment Industry Drivers
  3. 4.3 Sepsis and Septic Shock Treatment Industry Opportunities and Challenges
  4. 4.4 Sepsis and Septic Shock Treatment Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Sepsis and Septic Shock Treatment Revenue (2021-2026)
  2. 5.2 Global Sepsis and Septic Shock Treatment Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Sepsis and Septic Shock Treatment Key Company Headquarters & Area Served
  4. 5.4 Global Sepsis and Septic Shock Treatment Company, Product Type & Application
  5. 5.5 Global Sepsis and Septic Shock Treatment Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Sepsis and Septic Shock Treatment Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Sepsis and Septic Shock Treatment Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Sepsis and Septic Shock Treatment Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 TEVA
  2. 6.1.1 TEVA Company Information
  3. 6.1.2 TEVA Business Overview
  4. 6.1.3 TEVA Sepsis and Septic Shock Treatment Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 TEVA Sepsis and Septic Shock Treatment Product Portfolio
  6. 6.1.5 TEVA Recent Developments
  7. 6.2 Johnson & Johnson
  8. 6.2.1 Johnson & Johnson Company Information
  9. 6.2.2 Johnson & Johnson Business Overview
  10. 6.2.3 Johnson & Johnson Sepsis and Septic Shock Treatment Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Johnson & Johnson Sepsis and Septic Shock Treatment Product Portfolio
  12. 6.2.5 Johnson & Johnson Recent Developments
  13. 6.3 Novartis
  14. 6.3.1 Novartis Company Information
  15. 6.3.2 Novartis Business Overview
  16. 6.3.3 Novartis Sepsis and Septic Shock Treatment Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Novartis Sepsis and Septic Shock Treatment Product Portfolio
  18. 6.3.5 Novartis Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Sepsis and Septic Shock Treatment Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Sepsis and Septic Shock Treatment Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 GlaxoSmithKline
  26. 6.5.1 GlaxoSmithKline Company Information
  27. 6.5.2 GlaxoSmithKline Business Overview
  28. 6.5.3 GlaxoSmithKline Sepsis and Septic Shock Treatment Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 GlaxoSmithKline Sepsis and Septic Shock Treatment Product Portfolio
  30. 6.5.5 GlaxoSmithKline Recent Developments
  31. 6.6 Bayer
  32. 6.6.1 Bayer Company Information
  33. 6.6.2 Bayer Business Overview
  34. 6.6.3 Bayer Sepsis and Septic Shock Treatment Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Bayer Sepsis and Septic Shock Treatment Product Portfolio
  36. 6.6.5 Bayer Recent Developments
  37. 6.7 AbbVie
  38. 6.7.1 AbbVie Company Information
  39. 6.7.2 AbbVie Business Overview
  40. 6.7.3 AbbVie Sepsis and Septic Shock Treatment Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 AbbVie Sepsis and Septic Shock Treatment Product Portfolio
  42. 6.7.5 AbbVie Recent Developments
  43. 6.8 Viatris
  44. 6.8.1 Viatris Company Information
  45. 6.8.2 Viatris Business Overview
  46. 6.8.3 Viatris Sepsis and Septic Shock Treatment Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Viatris Sepsis and Septic Shock Treatment Product Portfolio
  48. 6.8.5 Viatris Recent Developments
  49. 6.9 Shanghai Pharmaceuticals
  50. 6.9.1 Shanghai Pharmaceuticals Company Information
  51. 6.9.2 Shanghai Pharmaceuticals Business Overview
  52. 6.9.3 Shanghai Pharmaceuticals Sepsis and Septic Shock Treatment Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Shanghai Pharmaceuticals Sepsis and Septic Shock Treatment Product Portfolio
  54. 6.9.5 Shanghai Pharmaceuticals Recent Developments
  55. 6.10 NCPC
  56. 6.10.1 NCPC Company Information
  57. 6.10.2 NCPC Business Overview
  58. 6.10.3 NCPC Sepsis and Septic Shock Treatment Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 NCPC Sepsis and Septic Shock Treatment Product Portfolio
  60. 6.10.5 NCPC Recent Developments
  61. 6.11 Merck & Co
  62. 6.11.1 Merck & Co Company Information
  63. 6.11.2 Merck & Co Business Overview
  64. 6.11.3 Merck & Co Sepsis and Septic Shock Treatment Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Merck & Co Sepsis and Septic Shock Treatment Product Portfolio
  66. 6.11.5 Merck & Co Recent Developments
  67. 6.12 INOTREM
  68. 6.12.1 INOTREM Company Information
  69. 6.12.2 INOTREM Business Overview
  70. 6.12.3 INOTREM Sepsis and Septic Shock Treatment Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 INOTREM Sepsis and Septic Shock Treatment Product Portfolio
  72. 6.12.5 INOTREM Recent Developments
  73. 6.13 Endacea
  74. 6.13.1 Endacea Company Information
  75. 6.13.2 Endacea Business Overview
  76. 6.13.3 Endacea Sepsis and Septic Shock Treatment Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Endacea Sepsis and Septic Shock Treatment Product Portfolio
  78. 6.13.5 Endacea Recent Developments
  79. 6.14 AtoxBio
  80. 6.14.1 AtoxBio Company Information
  81. 6.14.2 AtoxBio Business Overview
  82. 6.14.3 AtoxBio Sepsis and Septic Shock Treatment Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 AtoxBio Sepsis and Septic Shock Treatment Product Portfolio
  84. 6.14.5 AtoxBio Recent Developments
  85. 6.15 Asahi Kasei
  86. 6.15.1 Asahi Kasei Company Information
  87. 6.15.2 Asahi Kasei Business Overview
  88. 6.15.3 Asahi Kasei Sepsis and Septic Shock Treatment Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Asahi Kasei Sepsis and Septic Shock Treatment Product Portfolio
  90. 6.15.5 Asahi Kasei Recent Developments
  91. 6.16 Adrenomed
  92. 6.16.1 Adrenomed Company Information
  93. 6.16.2 Adrenomed Business Overview
  94. 6.16.3 Adrenomed Sepsis and Septic Shock Treatment Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Adrenomed Sepsis and Septic Shock Treatment Product Portfolio
  96. 6.16.5 Adrenomed Recent Developments
7 North America
  1. 7.1 North America Sepsis and Septic Shock Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Sepsis and Septic Shock Treatment Market Size by Country (2021-2026)
  3. 7.3 North America Sepsis and Septic Shock Treatment Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Sepsis and Septic Shock Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Sepsis and Septic Shock Treatment Market Size by Country (2021-2026)
  3. 8.3 Europe Sepsis and Septic Shock Treatment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Sepsis and Septic Shock Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Sepsis and Septic Shock Treatment Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Sepsis and Septic Shock Treatment Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Sepsis and Septic Shock Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Sepsis and Septic Shock Treatment Market Size by Country (2021-2026)
  3. 10.3 South America Sepsis and Septic Shock Treatment Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Sepsis and Septic Shock Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Sepsis and Septic Shock Treatment Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Sepsis and Septic Shock Treatment Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst